Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y5AM
|
||||
Former ID |
DAP001131
|
||||
Drug Name |
Darifenacin
|
||||
Synonyms |
Emselex; Emselex (TN); Enablex (TN); Darifenacin (USAN/INN); (S)-1-(2-(2,3-Dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide; 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide; 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Urinary antispasmodics
|
||||
Company |
Norvatis Phamaceuticals Corporation
|
||||
Structure |
Download2D MOL |
||||
Formula |
C28H30N2O2
|
||||
InChI |
InChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1
|
||||
InChIKey |
HXGBXQDTNZMWGS-RUZDIDTESA-N
|
||||
CAS Number |
CAS 133099-04-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7979027, 10944518, 14856314, 17397751, 36887144, 46508104, 50070895, 50113277, 50275204, 81145912, 85083117, 85583237, 92719451, 103435149, 104004586, 104631174, 126620787, 126651550, 128126220, 134338376, 135030473, 135650160, 135651146, 136947991, 137004287, 142807983, 144240344, 152047381, 160963842, 163621141, 163686486, 164826587, 175268333, 179149827, 186007015, 196107254, 223541474, 223831811, 226439188, 241032006, 249858507, 251916719, 251917958, 252215250
|
||||
SuperDrug ATC ID |
G04BD10
|
||||
Target and Pathway | |||||
Target(s) | Muscarinic acetylcholine receptor M3 | Target Info | Antagonist | [537284] | |
PathWhiz Pathway | Gastric Acid Production | ||||
References | |||||
Ref 527466 | 2004 approvals: the demise of the blockbuster. Nat Rev Drug Discov. 2005 Feb;4(2):93-4. | ||||
Ref 536361 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. | ||||
Ref 540188 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 321). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.